Mitchell S. Analyst PerformanceBiotech Analyst at HC WainwrightMitchell S. is a stock analyst at HC Wainwright focused in the medical sector, covering 30 publicly traded companies. Over the past year, Mitchell S. has issued 127 stock ratings, including buy, hold, and sell recommendations. While full access to Mitchell S.'s proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mitchell S.'s coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings127 Last 0 YearsBuy Recommendations86.61% 110 Buy RatingsCompanies Covered30 Unique Companies Ratings Distribution127RatingsDistribution of strong buy, buy, hold, and sell ratings by Mitchell S..RatingPercentageCount Strong Buy0.0%0 ratings Buy86.6%110 ratings Hold9.4%12 ratings Sell3.9%5 ratingsOut of 127 total stock ratings issued by Mitchell S. at HC Wainwright, the majority (86.6%) have been Buy recommendations, followed by 9.4% Hold and 3.9% Sell.Best & Worst CallsThis analyst does not have any ratings with enough history to determine best and worst calls.Exchange CoverageExchangePercentageCountNASDAQ96.7% of companies on NASDAQ29 companiesNYSE3.3% of companies on NYSE1 companyMitchell S., an analyst at HC Wainwright, currently covers 30 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical28 companies93.3%Manufacturing2 companies6.7%Mitchell S. of HC Wainwright specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE18 companies60.0%MED - DRUGS9 companies30.0%Miscellaneous2 companies6.7%PHARMACEUTICAL PREPARATIONS1 company3.3% Mitchell S.'s Ratings History at HC Wainwright Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsINCYIncyte6/24/2026Reiterated Rating$104.40$140.00Buy$0.0000.00% ROIORKAOruka Therapeutics6/23/2026Reiterated Rating$85.38$120.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical6/22/2026Reiterated Rating$54.69Neutral$0.0000.00% ROIHALOHalozyme Therapeutics6/16/2026Reiterated Rating$71.28Buy$0.0000.00% ROINTLAIntellia Therapeutics6/15/2026Reiterated Rating$12.11$25.00Buy$0.0000.00% ROIDMRADamora Therapeutics, Inc. Common Stock6/11/2026Initiated Coverage$20.15$45.00Buy$0.0000.00% ROILYELLyell Immunopharma6/9/2026Reiterated Rating$12.31$45.00Buy$0.0000.00% ROINGNENeurogene6/9/2026Reiterated Rating$28.60$70.00Buy$0.0000.00% ROIINCYIncyte6/9/2026Boost Price Target$103.11$140.00Buy$0.0000.00% ROIORKAOruka Therapeutics6/3/2026Reiterated Rating$55.23Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. KYTXKyverna Therapeutics6/3/2026Reiterated Rating$7.86$25.00Buy$0.0000.00% ROILEGNLegend Biotech6/3/2026Boost Price Target$36.28$65.00Buy$0.0000.00% ROILYELLyell Immunopharma6/3/2026Reiterated Rating$14.89$45.00Buy$0.0000.00% ROILEGNLegend Biotech5/27/2026Reiterated Rating$29.53Buy$0.0000.00% ROIIONSIonis Pharmaceuticals5/27/2026Reiterated Rating$76.07$125.00Buy$0.0000.00% ROIEVMNEvommune5/26/2026Reiterated Rating$22.74$50.00Buy$0.0000.00% ROISMMTSummit Therapeutics5/22/2026Downgrade$17.47Neutral$0.0000.00% ROIINCYIncyte5/21/2026Reiterated Rating$97.08$135.00Buy$0.0000.00% ROIKRROKorro Bio5/19/2026Lower Price Target$9.97$15.00Buy$0.0000.00% ROILEGNLegend Biotech5/18/2026Reiterated Rating$27.55$50.00Buy$0.0000.00% ROIORKAOruka Therapeutics5/18/2026Reiterated Rating$61.93$120.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical5/18/2026Lower Price Target$50.63$50.00Neutral$0.0000.00% ROIALMSAlumis5/15/2026Downgrade$24.63$25.00Neutral$0.0000.00% ROIKYTXKyverna Therapeutics5/15/2026Boost Price Target$10.74$25.00Buy$0.0000.00% ROITYRATyra Biosciences5/14/2026Reiterated Rating$36.18$45.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics5/14/2026Lower Price Target$19.85$35.00Buy$0.0000.00% ROINTLAIntellia Therapeutics5/13/2026Lower Price Target$13.99$25.00Buy$0.0000.00% ROIRNACCartesian Therapeutics5/12/2026Lower Price Target$8.53$25.00Buy$0.0000.00% ROICTMXCytomX Therapeutics5/11/2026Lower Price Target$3.98$11.00Buy$0.0000.00% ROIGENBGenerate Biomedicines5/8/2026Boost Price Target$13.59$25.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical5/5/2026Reiterated Rating$55.46$55.00Neutral$0.0000.00% ROIINCYIncyte5/4/2026Reiterated Rating$96.91$135.00Buy$0.0000.00% ROISMMTSummit Therapeutics5/4/2026Lower Price Target$16.11$23.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals4/30/2026Boost Price Target$74.83$125.00Buy$0.0000.00% ROIORKAOruka Therapeutics4/29/2026Boost Price Target$73.99$120.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics4/29/2026Boost Price Target$63.86$95.00Buy$0.0000.00% ROIKYTXKyverna Therapeutics4/23/2026Reiterated Rating$10.23$20.00Buy$0.0000.00% ROILEGNLegend Biotech4/21/2026Reiterated Rating$25.07$50.00Buy$0.0000.00% ROISRPTSarepta Therapeutics4/16/2026Reiterated Rating$21.07Sell$0.0000.00% ROILEGNLegend Biotech4/15/2026Reiterated Rating$18.69$50.00Buy$0.0000.00% ROIIran War Shock: What I Was Told In That Private Meeting (Ad)You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.Because THIS is the real reason.INCYIncyte4/15/2026Reiterated Rating$97.69$135.00Buy$0.0000.00% ROIORKAOruka Therapeutics4/13/2026Boost Price Target$59.58$70.00Buy$0.0000.00% ROIGENBGenerate Biomedicines4/13/2026Initiated Coverage$11.41$16.00Buy$0.0000.00% ROIALMSAlumis3/30/2026Lower Price Target$24.80$25.00Buy$0.0000.00% ROIPALIPalisade Bio3/26/2026Initiated Coverage$2.00$7.00Buy$0.0000.00% ROIINCYIncyte3/25/2026Reiterated Rating$90.62$135.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics3/25/2026Boost Price Target$13.45$40.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals3/25/2026Boost Price Target$73.05$120.00Buy$0.0000.00% ROIEVMNEvommune3/18/2026Lower Price Target$24.99$50.00Buy$0.0000.00% ROICTMXCytomX Therapeutics3/16/2026Boost Price Target$7.81$17.00Buy$0.0000.00% ROIINCYIncyte3/9/2026Reiterated Rating$95.94$135.00Buy$0.0000.00% ROINTLAIntellia Therapeutics3/3/2026Boost Price Target$15.44$30.00Buy$0.0000.00% ROISRPTSarepta Therapeutics3/2/2026Reiterated Rating$16.76Sell$0.0000.00% ROICBIOCrescent Biopharma3/2/2026Lower Price Target$12.09$22.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical2/25/2026Lower Price Target$62.62$55.00Neutral$0.0000.00% ROISMMTSummit Therapeutics2/24/2026Lower Price Target$16.09$30.00Buy$0.0000.00% ROITYRATyra Biosciences2/17/2026Boost Price Target$27.99$45.00Buy$0.0000.00% ROIINCYIncyte2/11/2026Reiterated Rating$100.05$135.00Buy$0.0000.00% ROIEVMNEvommune2/10/2026Boost Price Target$25.02$65.00Buy$0.0000.00% ROISMMTSummit Therapeutics2/2/2026Reiterated Rating$14.48$40.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics1/29/2026Reiterated Rating$71.70Buy$0.0000.00% ROINTLAIntellia Therapeutics1/28/2026Boost Price Target$14.83$25.00Buy$0.0000.00% ROISRPTSarepta Therapeutics1/27/2026Reiterated Rating$22.80Sell$0.0000.00% ROILEGNLegend Biotech1/22/2026Lower Price Target$20.76$50.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics1/15/2026Reiterated Rating$16.19$25.00Buy$0.0000.00% ROISMMTSummit Therapeutics1/14/2026Reiterated Rating$16.81Buy$0.0000.00% ROISRPTSarepta Therapeutics1/14/2026Reiterated Rating$21.46Sell$0.0000.00% ROILXEOLexeo Therapeutics1/13/2026Lower Price Target$8.12$10.00Buy$0.0000.00% ROINGNENeurogene1/13/2026Reiterated Rating$17.28$70.00Buy$0.0000.00% ROIALMSAlumis1/9/2026Reiterated Rating$18.18$40.00Buy$0.0000.00% ROITILInstil Bio1/7/2026Reiterated Rating$7.03Neutral$0.0000.00% ROIBMRNBioMarin Pharmaceutical12/22/2025Boost Price Target$61.15$60.00Neutral$0.0000.00% ROIHALOHalozyme Therapeutics12/19/2025Reiterated Rating$65.11$90.00Buy$0.0000.00% ROIALMSAlumis12/18/2025Boost Price Target$11.03$20.00Buy$0.0000.00% ROILYELLyell Immunopharma12/9/2025Upgrade$28.36$45.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics11/28/2025Reiterated Rating$72.66$90.00Buy$0.0000.00% ROILEGNLegend Biotech11/26/2025Reiterated Rating$28.19Buy$0.0000.00% ROIRNACCartesian Therapeutics11/19/2025Lower Price Target$7.62$30.00Buy$0.0000.00% ROINGNENeurogene11/13/2025Boost Price Target$31.08$70.00Buy$0.0000.00% ROIKRROKorro Bio11/13/2025Reiterated Rating$31.42Neutral$0.0000.00% ROICTMXCytomX Therapeutics11/11/2025Boost Price Target$4.19$10.00Buy$0.0000.00% ROINTLAIntellia Therapeutics11/10/2025Lower Price Target$9.52$15.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals11/10/2025Boost Price Target$73.55$110.00Buy$0.0000.00% ROILXEOLexeo Therapeutics11/3/2025Reiterated Rating$9.01Buy$0.0000.00% ROINGNENeurogene10/31/2025Boost Price Target$33.14$65.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals10/30/2025Boost Price Target$73.46$100.00Buy$0.0000.00% ROINTLAIntellia Therapeutics10/27/2025Lower Price Target$14.48$25.00Buy$0.0000.00% ROIORKAOruka Therapeutics10/27/2025Lower Price Target$27.25$40.00Buy$0.0000.00% ROIKYTXKyverna Therapeutics10/27/2025Boost Price Target$7.44$20.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical10/27/2025Lower Price Target$52.67$55.00Neutral$0.0000.00% ROIStranded On The Flood Plains of History (Ad)The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed U.S. Treasury holdings by 45% from peak, and central banks are swapping dollars for gold at the fastest pace since the Cold War. Porter Stansberry believes Trump is channeling more than $3 trillion toward securing the minerals, chips, and infrastructure that make AI possible - and companies at those chokepoints like Vertiv (up 500%), GE Vernova (up 700%), and Arista Networks (up 750%) are already moving. Porter's new briefing names one asset to buy today plus five stocks positioned at the narrowest chokepoints of what he calls the Silicon Dollar.Read Porter's full briefing and get the ticker names todayHALOHalozyme Therapeutics10/21/2025Reiterated Rating$66.47Buy$0.0000.00% ROISMMTSummit Therapeutics10/21/2025Lower Price Target$20.03$40.00Buy$0.0000.00% ROILXEOLexeo Therapeutics10/21/2025Lower Price Target$9.22$13.00Buy$0.0000.00% ROILEGNLegend Biotech10/17/2025Lower Price Target$32.36$60.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics10/15/2025Reiterated Rating$66.65$90.00Buy$0.0000.00% ROINGNENeurogene10/9/2025Reiterated Rating$28.20$45.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals10/8/2025Reiterated Rating$68.94$95.00Buy$0.0000.00% ROILXEOLexeo Therapeutics10/7/2025Boost Price Target$8.42$15.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics10/2/2025Boost Price Target$74.94$90.00Buy$0.0000.00% ROICRSPCRISPR Therapeutics9/23/2025Reiterated Rating$62.10$80.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals9/23/2025Reiterated Rating$61.36$95.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics9/22/2025Boost Price Target$77.81$85.00Buy$0.0000.00% ROINTLAIntellia Therapeutics9/19/2025Boost Price Target$16.11$30.00Buy$0.0000.00% ROISMMTSummit Therapeutics9/16/2025Reiterated Rating$18.94$50.00Buy$0.0000.00% ROITILInstil Bio9/11/2025Reiterated Rating$24.16$125.00Buy$0.0000.00% ROISMMTSummit Therapeutics9/8/2025Reiterated Rating$25.98$50.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical9/8/2025Initiated Coverage$57.77$60.00Neutral$0.0000.00% ROIEDITEditas Medicine9/5/2025Reiterated Rating$2.52$5.00Buy$0.0000.00% ROISMMTSummit Therapeutics9/2/2025Reiterated Rating$23.70$50.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals9/2/2025Boost Price Target$42.63$95.00Buy$0.0000.00% ROISMMTSummit Therapeutics8/27/2025Boost Price Target$26.98$50.00Buy$0.0000.00% ROICBIOCrescent Biopharma8/27/2025Reiterated Rating$14.47$25.00Buy$0.0000.00% ROITILInstil Bio8/27/2025Reiterated Rating$28.41$125.00Buy$0.0000.00% ROISRPTSarepta Therapeutics8/25/2025Reiterated Rating$20.22Sell$0.0000.00% ROIIONSIonis Pharmaceuticals8/22/2025Boost Price Target$43.24$70.00Buy$0.0000.00% ROITYRATyra Biosciences8/22/2025Reiterated Rating$11.70$30.00Buy$0.0000.00% ROIMGXMetagenomi8/19/2025Reiterated Rating$1.92$7.00Buy$0.0000.00% ROIZURAZura Bio8/19/2025Lower Price Target$1.74$2.00Neutral$0.0000.00% ROIORKAOruka Therapeutics8/18/2025Reiterated Rating$15.37$45.00Buy$0.0000.00% ROILXEOLexeo Therapeutics8/15/2025Lower Price Target$4.79$9.00Buy$0.0000.00% ROITILInstil Bio8/15/2025Reiterated Rating$28.25$125.00Buy$0.0000.00% ROISMMTSummit Therapeutics8/15/2025Reiterated Rating$26.45$44.00Buy$0.0000.00% ROIALMSAlumis8/14/2025Reiterated Rating$4.42$14.00Buy$0.0000.00% ROIKRROKorro Bio8/13/2025Lower Price Target$15.99$90.00Buy$0.0000.00% ROICBIOCrescent Biopharma8/11/2025Initiated Coverage$12.85$25.00Buy$0.0000.00% ROIBOLDBoundless Bio8/11/2025Lower Price Target$1.10$4.00Buy$0.0000.00% ROINTLAIntellia Therapeutics8/8/2025Lower Price Target$11.46$25.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageRoth MkmWall Street ZenUBS GroupCitigroupBarclaysMorgan StanleyWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
